by Internet Medical Society

Annie pery
  • Female
  • Belgium
Share on Facebook
  • Blog Posts
  • Discussions (40)
  • Groups
  • Photos
  • Photo Albums
  • Videos

Annie pery's Discussions

Enzalutamide 40 mg: A Promising Prostate Cancer Therapy

Started 16 hours ago 0 Replies

Enzalutamide 40 mg is approved to treat sufferers with prostate cancer. It may also be used for other conditions, as determined by a health specialist. The…Continue

Tags: price, mg, 40, enzalutamide

Sorafenib: As An Antineoplastic Agent

Started 18 hours ago 0 Replies

Sorafenib is approved as an antineoplastic agent to treat liver cancer and thyroid cancer. It can also be used to treat advanced kidney cancer when standard therapy cannot cure the disease. The…Continue

Tags: price, sorafenib

Mitomycin C 40mg: An antibiotic Chemotherapeutic Agent

Started yesterday 0 Replies

The injection Mitomycin C 40mg is developed to be used alone or in combination with some medicines as part of combination chemotherapy. The…Continue

Tags: mg, 40, c, mitomycin

Manual for the medicine Gefitinib

Started on Tuesday 0 Replies

Healthcare professionals recommended this medicine to treat patients with metastatic non-small cell lung cancer. The drug Gefitinib is a kinase inhibitor that reverses the kinase activity of…Continue

Tags: cost, Gefitinib


Annie pery's Page

Latest Activity

Annie pery posted discussions
16 hours ago
Annie pery posted discussions
Annie pery posted discussions
Annie pery posted discussions
Jan 14
Annie pery posted a discussion

Ibrunat A Tyrosine Kinase Inhibitor

Ibrutinib tablet is used alone or with other drugs to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or Waldenstrom macroglobulinemia. The ibrunat 140 mg price in India is reasonable at every certified (ISO and WHO-GDP) pharmaceutical wholesaler or pharmacy. Ibrunat is also used to treat adults with mantle cell lymphoma or marginal zone lymphoma. This…See More
Jan 13
Annie pery posted discussions
Jan 12
Annie pery posted a discussion

Ribociclib succinate A crystalline powder

Ribociclib succinate comes in a light yellow to yellowish-brown crystalline powder, and the medicine comes in the form of tablets of 200 mg for oral administration via the mouth. Ribociclib is a cyclin-dependent kinase (CDK) 4 and 6 inhibitor. Healthcare professionals recommend using the medicine Ribociclib which is composed of Ribociclib succinate as the active ingredient, and the inactive ingredients are colloidal silicon dioxide, crospovidone, hydroxypropyl cellulose, magnesium stearate, and…See More
Jan 10
Annie pery posted discussions
Jan 7
Annie pery posted discussions
Jan 5
Annie pery posted a discussion

Thalidomide: A Drug Therapy to Treat Multiple Myeloma

Thalidomide is prescribed along with dexamethasone to treat MM (bone marrow cancer). It is also prescribed to treat and prevent moderate/severe skin lesions caused by leprosy. As a thalidomide warning, never use it in case you are pregnant. Even one thalidomide dose may cause severe, life-threatening birth defects or death of a fetus if the…See More
Jan 4
Annie pery posted a discussion

Nintedanib: An Oral Therapy for NSCLC

Nintedanib is used with docetaxel for adults with locally advanced, metastatic or locally recurrent NSCLC of adenocarcinoma tumour histology following first-line chemotherapy. The nintedanib for non-small cell lung cancer in combination with medicine docetaxel is an effective treatment option. The recommended dosage of…See More
Dec 31, 2021
Annie pery posted discussions
Dec 30, 2021
Annie pery posted a discussion

PsA: An Autoimmune, Inflammatory Disease

PsA, an autoimmune, inflammatory disease can reach beyond skin and joints in order to attack organs and more. You’ll probably think of skin issues first, but certain organs affected by psoriatic arthritis (PsA) include the heart, gastrointestinal (GI) tract (stomach, intestines), eyes, lungs, liver, and kidneys. Psoriatic arthritis can start at any…See More
Dec 28, 2021
Annie pery posted a discussion

Sorafenib: An FDA approve drug

Sorafenib: An FDA approve drugThe FDA approved the drug Sorafenib, a kinase inhibitor that decreases tumor cell proliferation. It is used in patients with unresectable hepatocellular carcinoma, locally recurrent or metastatic, progressive, differentiated thyroid carcinoma, and advanced renal cell carcinoma. The medicine comprises Sorafenib tosylate as an active ingredient and inactive ingredients such as croscarmellose sodium, microcrystalline cellulose, hypromellose, sodium lauryl sulphate,…See More
Dec 23, 2021
Annie pery posted discussions
Dec 22, 2021
Annie pery posted discussions
Dec 16, 2021

Comment Wall

You need to be a member of to add comments!


  • No comments yet!


Interested in advertising on





Submit your manuscript

© 2022   Created by Network Admin.   Powered by

Badges  |  Report an Issue  |  Terms of Service